The FY2025 (Sep) proxy of Twist Bioscience names 17 peer companies for pay. Among Twist Bioscience and these peers, CEO pay was 3rd highest of 7 and total shareholder return was 4th highest of 7.
3rd highest of 7in Twist Bioscience and its pay peers, FY2025 (Sep) by CEO pay:
$4.1M$15.0M
4th highest of 7in Twist Bioscience and its pay peers, FY2025 (Sep) by total shareholder return:
$12$523
Pay peer group, FY2025 (Sep) proxy
| Natera | ||
| INSMED | ||
| Ultragenyx Pharmaceutical | ||
| Veracyte | ||
| 10x Genomics | ||
| Schrodinger | ||
| Azenta, Inc. | Not disclosed | Not disclosed |
| BioLife Solutions, Inc. | Not disclosed | Not disclosed |
| CareDX, Inc. | Not disclosed | Not disclosed |
| Cytek Biosciences, Inc. | Not disclosed | Not disclosed |
| Guardant Health | Not disclosed | Not disclosed |
| Maravai LifeSciences Holdings, Inc. | Not disclosed | Not disclosed |
| NeoGenomics, Inc. | Not disclosed | Not disclosed |
| NovoCure Limited | Not disclosed | Not disclosed |
| Pacific Biosciences of California, Inc. | Not disclosed | Not disclosed |
| Quanterix Corporation | Not disclosed | Not disclosed |
| REGENXBIO Inc. | Not disclosed | Not disclosed |
17 companies
Changes by year
FY2023 (Sep) proxy
- AddedBioLife Solutionspay peer group
- AddedCytekpay peer group
- AddedGuardantpay peer group
- AddedREGENXBIOpay peer group
- AddedSchrodingerpay peer group
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.